Alterity Therapeutics Limited ( ATHE) - Key Metrics
ATHE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $0 | -$0.77 | -$0.71 | $0 |
| 2026Q2 | $0 | -$0.56 | -$0.61 | $0 |
| 2025Q4 | $0.31 | -$0.40 | -$0.19 | -$0.19 |
| 2025Q2 | $0.19 | -$0.84 | -$0.98 | -$0.98 |
| 2024Q4 | $0.20 | -$1.20 | -$0.77 | -$0.77 |
ATHE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | -2.49 |
| 2026Q2 | 0% | -2.14 |
| 2025Q4 | 0% | -3.70 |
| 2025Q2 | 0% | -1.59 |
| 2024Q4 | 0% | -0.56 |
ATHE
Price: $3.12
52 week price:
Earnings Per Share: -0.96 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Volume: 8900
Market Capitalization: 58.4 million